Biofrontera AG
FSX:B8F.DE
6.804 (EUR) • At close May 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 32.249 | 25.738 | 28.787 | 30.346 | 31.265 | 21.107 | 12.025 | 6.13 | 4.138 | 3.096 | 3.115 | 3.431 | 0.515 | 0.406 | 0.336 |
| Cost of Revenue
| 6.88 | 4.756 | 3.913 | 3.536 | 4.875 | 4.451 | 1.715 | 1.652 | 1.236 | 1.117 | 1.604 | 1.508 | 0.445 | 0.171 | 0.006 |
| Gross Profit
| 25.369 | 20.982 | 24.874 | 26.81 | 26.39 | 16.656 | 10.31 | 4.478 | 2.902 | 1.979 | 1.511 | 1.923 | 0.07 | 0.235 | 0.33 |
| Gross Profit Ratio
| 0.787 | 0.815 | 0.864 | 0.883 | 0.844 | 0.789 | 0.857 | 0.73 | 0.701 | 0.639 | 0.485 | 0.561 | 0.137 | 0.58 | 0.982 |
| Reseach & Development Expenses
| 7.68 | 7.128 | 7.009 | 4.789 | 4.636 | 4.427 | 4.225 | 4.64 | 6.204 | 4.534 | 3.186 | 1.384 | 1.401 | 3.93 | 3.401 |
| General & Administrative Expenses
| 6.105 | 5.906 | 30.781 | 9.15 | 16.275 | 12.963 | 3.097 | 2.853 | 2.759 | 3.124 | 5.462 | 4.092 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 7.273 | 6.357 | 22.423 | 20.482 | 28.856 | 17.744 | 16.922 | 8.763 | 4.17 | 3.847 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.907 | 12.263 | 53.204 | 29.632 | 45.131 | 30.707 | 20.019 | 11.616 | 6.929 | 6.972 | 5.462 | 4.092 | 3.043 | 6.354 | 5.77 |
| Other Expenses
| 0.35 | -0.467 | 60.001 | -2.419 | 21.184 | 0.969 | -1.073 | 2.404 | 0.187 | -0.095 | 0.304 | 0.104 | 1.651 | 0.1 | 0.653 |
| Operating Expenses
| 20.587 | 19.391 | 60.213 | 34.421 | 49.767 | 35.134 | 24.244 | 16.257 | 13.133 | 11.506 | 8.649 | 5.476 | 4.444 | 6.354 | 5.77 |
| Operating Income
| 4.782 | 1.59 | 39.403 | -7.611 | -2.066 | -18.478 | -13.934 | -11.779 | -10.231 | -9.527 | -7.138 | -3.553 | -4.374 | -6.118 | -5.439 |
| Operating Income Ratio
| 0.148 | 0.062 | 1.369 | -0.251 | -0.066 | -0.875 | -1.159 | -1.921 | -2.472 | -3.078 | -2.292 | -1.035 | -8.488 | -15.074 | -16.173 |
| Total Other Income Expenses Net
| 0.356 | -44.8 | -3.72 | -5.086 | -2.711 | 0.969 | -1.073 | 2.404 | 0.187 | -0.095 | 0.304 | 0.104 | 1.651 | 0.1 | 0.653 |
| Income Before Tax
| 5.138 | -43.21 | 35.683 | -12.697 | -4.777 | -19.269 | -16.102 | -10.579 | -11.203 | -10.721 | -8.067 | -4.103 | -4.644 | -7.657 | -3.339 |
| Income Before Tax Ratio
| 0.159 | -1.679 | 1.24 | -0.418 | -0.153 | -0.913 | -1.339 | -1.726 | -2.707 | -3.463 | -2.59 | -1.196 | -9.012 | -18.865 | -9.929 |
| Income Tax Expense
| -1.758 | 0.956 | 2.397 | 0.326 | 2.581 | -10.391 | 2.168 | 0 | 0.972 | 1.194 | 0.929 | 0.015 | 0.27 | 1.539 | 0.086 |
| Net Income
| -0.369 | -44.166 | 37.747 | -13.023 | -7.358 | -8.878 | -16.102 | -10.579 | -11.203 | -10.721 | -8.067 | -4.118 | -4.644 | -7.657 | -3.425 |
| Net Income Ratio
| -0.011 | -1.716 | 1.311 | -0.429 | -0.235 | -0.421 | -1.339 | -1.726 | -2.707 | -3.463 | -2.59 | -1.2 | -9.012 | -18.865 | -10.184 |
| EPS
| -0.006 | -0.77 | 0.66 | -0.22 | -0.15 | -0.19 | -0.39 | -0.33 | -0.43 | -0.38 | -0.28 | -0.14 | -0.33 | -0.66 | -0.48 |
| EPS Diluted
| -0.006 | -0.77 | 0.65 | -0.22 | -0.15 | -0.19 | -0.39 | -0.33 | -0.43 | -0.38 | -0.28 | -0.14 | -0.33 | -0.66 | -0.48 |
| EBITDA
| 5.573 | -42.301 | 42.693 | -4.284 | 1.09 | -16.731 | -14.085 | -8.541 | -9.223 | -8.62 | -6.396 | -2.909 | -4.012 | -5.801 | -4.885 |
| EBITDA Ratio
| 0.173 | -1.644 | 1.483 | -0.141 | 0.035 | -0.793 | -1.171 | -1.393 | -2.229 | -2.785 | -2.053 | -0.848 | -7.786 | -14.292 | -14.524 |